Clinical Trials · NCT04465396

A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Pen Injector in Healthy Adult Participants

Name: A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Pen Injector in Healthy Adult Participants
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 1Teduglutide

Phase: Phase 1
Recruitment status: Completed
Sponsor: Shire
Enrollment: 64
Start date: Jan 2021
Locations: 1 site, United States
Primary endpoint: Area Under the Plasma Concentration Verse Time Curve From Time Zero to the Time of Last Measurable Concentration (AUC0-last) of Teduglutide

View Teduglutide compound reference